A large, three-year clinical trial designed to demonstrate how Grail’s blood test for early cancer detection could work in a broad population has preliminary results showing reduction in cancer diagnoses, but not enough to be statistically significant. The outcome means this test, named Galleri, failed to meet the main goal of the study. Grail did […]





